Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: A prospective, randomized, open-label, cross-over study

BACKGROUND: Trimetazidine (TMZ) modulates cardiac metabolism, but its use in heart failure remains controversial. The aim of the study was to evaluate the effects of TMZ on exercise capacity, left ventricular ejection fraction (LVEF), mortality, and quality of life in stable patients with heart fail...

Descripció completa

Dades bibliogràfiques

Autors principals:	Michał Bohdan, Iwona Stopczyńska, Piotr Wiśniewski, Joanna Moryś, Piotr Niedoszytko, Marcin Gruchała
Format:	Artigo
Idioma:	Inglês
Publicat:	Via Medica 2022-07-01
Col·lecció:	Cardiology Journal
Matèries:	trimetazidine heart failure cardiac metabolism exercise capacity echocardiography prognosis
Accés en línia:	https://journals.viamedica.pl/cardiology_journal/article/view/65841
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!